Key Insights

Highlights

Treatment Research

1 treatments under study, led by Allogeneic Cart

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07113496Phase 1Not Yet Recruiting

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Showing all 1 trials

Research Network

Common Treatments

  • Allogeneic Cart1

Active Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Top Investigators

  • Lei Fan1

    The First Affiliated Hospital with Nanjing Medical University

Related Conditions

  • Bcell Acute Lymphoblastic Leukemia Ball1
  • Multiple Myeloma Mm1
  • Relapsed Or Refractory Bcell Hematologic Malignancies1
  • Plasmablastic Lymphoma1
  • Mature Bcell Lymphoma1

Activity Timeline